
EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: Defining the future

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Vascular access

PCR LV 2021: Navitor™

Navitor™: Voice of the Experts Lars Sondergaard

Luca's testimonial

HFA 2023: Quality of life

AV VALVES 2023: Trending Topics – Timing

Mechanical Heart Valve Patient Story: Sadie

AV VALVES 2023: TA, TF in TMVR